Published in N Engl J Med on January 27, 2000
Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25
Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr (2005) 2.20
Mass influenza vaccination in Ontario: a sensible move. CMAJ (2001) 1.10
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res (2012) 0.92
Influenza diagnosis and treatment: a view from clinical practice. Philos Trans R Soc Lond B Biol Sci (2001) 0.82
Influenza related hospitalisations in Sydney, New South Wales, Australia. Arch Dis Child (2006) 0.80
Influenza vaccination options to prevent hospitalization. Paediatr Child Health (2003) 0.75
Vaccination updates. West J Med (2000) 0.75
Influenza pandemic planning and the paediatrician. Paediatr Child Health (2000) 0.75
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis (1979) 3.49
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis (1978) 2.32
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr (1980) 2.07
Coronaviridae: second report. Intervirology (1978) 2.05
Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65
Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65
Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64
Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Coronaviridae. Intervirology (1975) 1.55
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49
Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol (1969) 1.48
Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41
Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41
The cost of health conditions in a health maintenance organization. Med Care Res Rev (2000) 1.40
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol (1989) 1.39
Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery. J Infect Dis (1992) 1.39
Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis (1989) 1.39
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38
Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol (2003) 1.38
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Multicenter study of strains of respiratory syncytial virus. J Infect Dis (1991) 1.34
Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. J Clin Microbiol (1979) 1.33
Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33
Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28
Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27
Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol (1986) 1.23
Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol (1982) 1.20
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med (1991) 1.20
Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet Med (2012) 1.18
Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J (2001) 1.17
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence. Diagn Microbiol Infect Dis (1984) 1.16
The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993. J Med Genet (1995) 1.16
Summary of a workshop on new and useful methods in rapid viral diagnosis. J Infect Dis (1984) 1.13
Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J Gen Virol (1987) 1.13
Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12
A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr (1984) 1.12
Type A2 influenza viral infections in children. Am J Dis Child (1978) 1.12
The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics (2001) 1.10
Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol (2000) 1.09
Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis (1989) 1.08
Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann Neurol (1994) 1.07
Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis (1985) 1.07
The use of gowns and masks to control respiratory illness in pediatric hospital personnel. J Pediatr (1981) 1.06
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.04
Risk of illness after exposure to a pediatric office. N Engl J Med (1985) 1.04
Respiratory syncytial virus infections in infants and children: diagnosis and treatment. Pediatr Rev (1987) 1.03
Neonatal mastitis. Clin Pediatr (Phila) (1986) 1.03
Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J Acquir Immune Defic Syndr (1992) 1.03
Enterovirus infections in neonates. J Pediatr (1976) 1.03
Lymphocytotoxic antibodies in multiple sclerosis. Clin Immunol Immunopathol (1977) 1.02
Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis (2000) 1.02
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin. J Pediatr (1972) 1.01
Bronchomammary axis in the immune response to respiratory syncytial virus. J Pediatr (1981) 1.00
Bronchiolitis and asthma: possible common pathogenetic pathways. J Allergy Clin Immunol (1976) 0.99
Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection. Gastroenterology (1991) 0.99